Predicting local control of choroidal melanomas following 106Ru plaque brachytherapy

British Journal of Ophthalmology

Volumn 95, Issue 2, 2011, Pages 166-170

  Papageorgiou, K I ^a   Cohen, Victoria ^a,b   Bunce, C ^b   Kinsella, M ^a   Hungerford, J L ^a,b  

^a BARTS HEALTH NHS TRUST   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOFUSCIN; RUTHENIUM 106;

ADULT; AGED; BRACHYTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CHOROID MELANOMA; DIODE LASER; FEMALE; FOLLOW UP; HUMAN; LASER THERMOTHERAPY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; RADIATION DOSE; RETINA FOVEA; REVIEW; SUBRETINAL FLUID; TREATMENT RESPONSE; TUMOR VOLUME; UNITED KINGDOM; UVEA MELANOMA;

AGED; BRACHYTHERAPY; CHOROID NEOPLASMS; FEMALE; HUMANS; LONDON; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; RUTHENIUM RADIOISOTOPES; TREATMENT OUTCOME; UVEAL NEOPLASMS;

EID: 79151471265     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.176198     Document Type: Review

References (29)

1. Eskelin S, Pyrhönen S, Summanen P, et al. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000;107:1443-9.
2. Char DH, Kroll S, Phillips TL. Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol 1997;115:1014-18.
3. Char DH, Kroll SM, Miller T, et al. Irradiated uveal melanomas: cytopathologic correlation with prognosis. Am J Ophthalmol 1996;122:509-13. (Pubitemid 26329685)
4. Lommatzsch PK, Werschnik C, Schuster E. Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefes Arch Clin Exp Ophthalmol 2000;238:129-37.
5. Gragoudas ES, Seddon JM, Egan K, et al. A. Long-term results of proton beam irradiated uveal melanomas. Ophthalmology 1987;94:349-53.
6. Harbour JW, Char DH, Kroll S, et al. Metastatic risk for distinct patterns of postirradiation local recurrence of posterior uveal melanoma. Ophthalmology 1997;104:1785-92; discussion 1792-3.
7. Gragoudas ES, Egan KM, Seddon JM, et al. Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology 1992;99:760-6.
8. Lommatzsch P, Vollmar R. [A new way in the conservative therapy of intraocular tumors by means of beta-irradiation (Ruthenium 106) with preservation of vision] (In German). Klin Monatsbl Augenheilkd 1966;148:682-99.
9. Rouberol F, Roy P, Kodjikian L, et al. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays). Am J Ophthalmol 2004;137:893-900. (Pubitemid 38582043)
10. Damato B, Patel I, Campbell IR, et al. Visual acuity after Ruthenium(106) brachytherapy of choroidal melanomas. Int J Radiat Oncol Biol Phys 2005;63:392-400.
11. Kleineidam M, Guthoff R, Bentzen SM. Rates of local control, metastasis, and overall survival in patients with posterior uveal melanomas treated with ruthenium- 106 plaques. Radiother Oncol 1993;28:148-56.
12. Jampol LM, Moy CS, Murray TG, et al. Collaborative Ocular Melanoma Study Group (COMS Group). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 2002;109:2197-206. Erratum in: Ophthalmology 2004 Aug;111(8):1514.
13. Melia M, Moy CS, Reynolds SM, et al. Collaborative Ocular Melanoma Study - Quality of Life Study Group. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol 2006;124:226-38.
14. Kreusel KM, Bechrakis N, Riese J, et al. Combined brachytherapy and transpupillary thermotherapy for large choroidal melanoma: tumor regression and early complications. Graefes Arch Clin Exp Ophthalmol 2006;244:1575-80.
15. Shields CL, Cater J, Shields JA, et al. Combined plaque radiotherapy and transpupillary thermotherapy for choroidal melanoma: tumor control and treatment complications in 270 consecutive patients. Arch Ophthalmol 2002;120:933-40.
16. Harbour JW, Meredith TA, Thompson PA, et al. Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas. Ophthalmology 2003;110:2207-14; discussion 2215.
17. Shields CL, Shields JA, Cater J, et al. Transpupillary thermotherapy for choroidal melanoma: tumor control and visual results in 100 consecutive cases. Ophthalmology 1998;105:581-90.
18. Sagoo MS, Shields CL, Mashayekhi A, et al. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients. Arch Ophthalmol 2008;126:1515-22.
19. Bartlema YM, Oosterhuis JA, Journée-De Korver JG, et al. Combined plaque radiotherapy and transpupillary thermotherapy in choroidal melanoma: 5 years' experience. Br J Ophthalmol 2003;87:1370-3.
20. Wilson MW, Hungerford JL. Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma. Ophthalmology 1999;106:1579-87.
21. Karlsson UL, Augsburger JJ, Shields JA, et al. Recurrence of posterior uveal melanoma after 60Co episcleral plaque therapy. Ophthalmology 1989;96:382-8.
22. Damato B, Patel I, Campbell IR, et al. Local tumor control after 106Ru brachytherapy of choroidal melanoma. Int J Radiat Oncol Biol Phys 2005;63:385-91.
23. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
24. Damms T, Schäfer H, Guthoff R, et al. Correlation of histological tumor vascularization and Doppler sonography in patients with malignant melanoma of the choroid. Graefes Arch Clin Exp Ophthalmol 1995;233:257-60.
25. Resch H, Garhöfer G, Schmetterer L, et al. Choroidal perfusion in eyes with untreated choroidal melanoma. Acta Ophthalmol 2008;86:404-7. Epub 2007 Nov 26.
26. Lischko AM, Seddon JM, Gragoudas ES, et al. Evaluation of prior primary malignancy as a determinant of uveal melanoma. A caseecontrol study. Ophthalmology 1989;96:1716-21.
27. Gündüz K, Shields CL, Shields JA, et al. Plaque radiotherapy of uveal melanoma with predominant ciliary body involvement. Arch Ophthalmol 1999;117:170-7.
28. Oosterhuis JA, Journée-de Korver HG, et al. Transpupillary thermotherapy: results in 50 patients with choroidal melanoma. Arch Ophthalmol 1998;116:157-62.
29. Hungerford JL. Current trends in the treatment of ocular melanoma by radiotherapy. Clin Experiment Ophthalmol 2003;31:8-13.